City of Hope
City of Hope, Institute for Follicular Lymphoma Innovation Partner on $2M Research Program
The three-year effort will use DNA profiling, proteomics, and machine learning techniques to explore potential triggers of spontaneous remission.
Tumor-derived and cell-free microRNAs showed high sensitivity and specificity for pancreatic cancer detection when combined with a CA 19-9 blood test.
City of Hope, Delfi Diagnostics Partner on Liquid Biopsy Lung Cancer Screening Study in LA
The study will provide Delfi's FirstLook Lung test for free to participants from underserved communities through community health centers and a mobile screening unit.
City of Hope, TGen Debut Amplicon-Based Fragmentomic Sequencing Method for Cancer Early Detection
Premium
Investigators are planning a prospective validation this summer in adults between 65 and 75 years of age, measuring their test's ability to detect incipient cancers.
City of Hope, TGen Win $4.5M Grant to Advance Pancreatic Cancer Liquid Biopsy Screening
A City of Hope-led consortium aims to validate a noninvasive screening test for pancreatic ductal adenocarcinoma in a large-scale, diverse cohort.